Congenital adrenal hyperplasia

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
Status:
Recruiting
Last Changed:
Jul 31, 2019
First Changed:
Nov 30, 2018
Disease(s):
Congenital Adrenal Hyperplasia
Intervention(s):
Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)Dual release hydrocortisone (plenadren)
Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
Status:
Completed
Last Changed:
Sep 14, 2015
First Changed:
Sep 14, 2007
Disease(s):
Adrenal Hyperplasia, Congenital
Intervention(s):
Hydrocortisone sodium acetate
Prenatal Dex Study
Status:
Recruiting
Last Changed:
Feb 23, 2017
First Changed:
Jun 10, 2016
Disease(s):
Congenital Adrenal Hyperplasia
Intervention(s):
Neuropsychological and cognitive assessment

Connect. Empower. Inspire.